De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder

Gregory M. Cooper(HudsonAlpha Institute for Biotechnology), Susan M. Hiatt(HudsonAlpha Institute for Biotechnology), Haley Streff(Baylor College of Medicine), Paulien A. Terhal(University Medical Center Utrecht), Holly Dubbs, Robert J. Hopkin(Cincinnati Children's Hospital Medical Center), Rolph Pfundt(Radboud University Nijmegen), Rosemarie Smith(Maine Medical Center), Han G. Brunner(Radboud University Nijmegen), Krysta L. Engel(HudsonAlpha Institute for Biotechnology), Heather M. McLaughlin, Kevin M. Bowling(HudsonAlpha Institute for Biotechnology), Sameer M. Zuberi(Carol Davila University of Medicine and Pharmacy), Amy Crunk, J. Nicholas Cochran(HudsonAlpha Institute for Biotechnology), Katherine S. Elliott(School of the Art Institute of Chicago), Xilma R. Ortiz‐González(Children's Hospital of Philadelphia), Marleen Simon(Erasmus University Rotterdam), Lot Snijders Blok(Radboud University Nijmegen), Abigail Masunga(Cincinnati Children's Hospital Medical Center), Simon E. Fisher(Radboud University Nijmegen), Claudia Ruivenkamp(The Netherlands Cancer Institute), Jeremy W. Prokop(HudsonAlpha Institute for Biotechnology), Joseph D. Symonds(Royal Hospital for Children), Michael F. Wangler(Baylor College of Medicine), Tjitske Kleefstra(Radboud University Nijmegen), E. Martina Bebin(University of Alabama at Birmingham), Richard Person(GenVec), Jane A. Hurst(Great Ormond Street Hospital), Emilia K. Bijlsma(Leiden University), Victoria R. Sanders(Lurie Children's Hospital)
Human Genetics
May 1, 2018
Cited by 80


Related Papers